TE_14908
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1PBa1_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 513.96 |
| Counts of samples | TCGA_tumor:455; TCGA_normal:0; GTEx:0 |
| TSS | chr6(+):84340629 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_14908.1 | - | Intergenic | Non-coding | Non-coding | chr6(+):84340630,84340752,84369918,84370010,84370444,84370464 |
| teRNA_14908.2 | - | Intergenic | Non-coding | Non-coding | chr6(+):84340630,84340752,84369918,84370010,84370444,84370673,84417593,84417613 |
| teRNA_14908.3 | - | Intergenic | Non-coding | Non-coding | chr6(+):84340630,84340752,84369918,84370010,84370444,84370673,84430035,84430055 |
| teRNA_14908.4 | - | Intergenic | Non-coding | Non-coding | chr6(+):84340630,84340752,84369918,84370010,84370444,84370673,84372335,84372355 |
| teRNA_14908.5 | - | Intergenic | Non-coding | Non-coding | chr6(+):84340630,84340752,84369918,84370010,84370444,84370673,84453267,84453287 |
| teRNA_14908.6 | - | Intergenic | Non-coding | Non-coding | chr6(+):84340630,84340752,84369918,84370010,84370444,84370673,84453267,84453327,84519753,84519773 |
| teRNA_14908.7 | - | Intergenic | Non-coding | Non-coding | chr6(+):84340630,84340752,84370444,84370673,84372335,84372355 |
| teRNA_14908.8 | - | Intergenic | Non-coding | Non-coding | chr6(+):84340630,84340752,84370444,84370673,84417593,84417613 |
| teRNA_14908.9 | - | Intergenic | Non-coding | Non-coding | chr6(+):84340630,84340752,84343652,84343731,84370444,84370464 |
| teRNA_14908.10 | - | Intergenic | Non-coding | Non-coding | chr6(+):84340630,84340752,84343652,84343731,84369918,84370010,84370444,84370464 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
